Drug resistance in the Philippines
Bustos, D.G.; Asinas, C.Y.; Gay, F.
Southeast Asian Journal of Tropical Medicine and Public Health 23(Suppl 4): 149-151
1992
ISSN/ISBN: 0125-1562 PMID: 1364862 Document Number: 395205
Document emailed within 1 workday
Related Documents
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Zarco, R.M.; Almonte, M.P. 1977: Drug abuse in the Philippines Addictive Diseases 3(1): 119-134
Jeffery, W. Bentley 1997: Local knowledge and agricultural decision making in the Philippines: Class, gender and resistance by Virginia D. Nazarea-Sandoval Agriculture and Human Values 14(4): 387-387
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Li, J.; Ma, Y.-x.; Zhang, Q.-b.; Zhou, Y.-a.; Shang, R.-p.; Li, P.-l.; Hao, Z.-q. 2013: Correlations of integrons and resistance gene cassettes in Gram-negative bacteria with multi-drug resistance Zhonghua Yi Xue Za Zhi 93(46): 3698-3702
Danks, M.K.; Yalowich, J.C.; Beck, W.T. 1987: Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26) Cancer Research 47(5): 1297-1301
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396
Rabinovich, S.A. 1976: Drug resistance in malaria parasites. 1. The nature of resistance, its distribution and epidemiological implications (review of the literature) Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(4): 464-477
Harada, Y.; Kitahara, Y.; Ninomiya, H.; Harada, S.; Takamoto, M.; Ishibashi, T. 1994: A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP Kekkaku: 69(12): 751-757
Pinet, N.; Stephan, J.F. 1990: The Philippine wrench fault system in the Ilicos Foothills, northwestern Luzon, Philippines - Le système faillé en décrochement vertical des Philippines au pied des Collines Ilocos (Ilocos Foothills), partie nord-ouest de Luzon, Philippines Tectonophysics 183(1-4): 207-224
Tanaka, M.; Kobayashi, Y.; Hanada, K.; Suganami, S.; Nakahara, T. 1997: A drug revolving fund program for rural villages in the Philippines Japanese Journal of Public Health 44(9): 713-723
Hamers, R.L.; Straatsma, E.; Kityo, C.; Wallis, C.L.; Stevens, W.S.; Sigaloff, K.C.E.; Siwale, M.; Conradie, F.; Botes, M.E.; Mandaliya, K.; Wellington, M.; Osibogun, A.; van Vugt, M.èl.; Rinke de Wit, T.F. 2012: Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S261-S265
Chevillard, S.; Vielh, P.; Validire, P.; Marie, J.P.; Faussat, A.M.; Barbu, V.; Bayle, C.; Bénard, J.; Bonnal, C.; Boutonnat, J.; Calvo, F.; Charrier, J.; Clary, A.; Colosetti, P.; Danel-Moore, L.; Decrémoux, P.; Delvincourt, C.; Finat-Duclos, F.; Genne, P.; Kataki, A.; Kouyoumdjian, J.C.; Lacave, R.; Maugard, C.; Merlin, J.L.; Robert, J. 1997: French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris Leukemia 11(7): 1095-1106
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Volm, M.; Bak, M.; Mattern, J. 1988: Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoproteins Arzneimittel-Forschung 38(8): 1189-1193
Orlov, V.S.; Rabinovich, S.A.; Bukhtin, B.A.; Dadasheva, N.R.; Maksakovskaia, E.V. 1998: Ca++ ion transport blockers as reversants of the drug resistance of malarial parasites. 2. the effect of praziquantel on the resistance to chloroquine and compound R-70-Zh of Plasmodium berghei Meditsinskaia Parazitologiia i Parazitarnye Bolezni 1: 26-29
Courcambeck, J.ér.ôm.; Bouzidi, M.; Perbost, R.ég.; Jouirou, B.; Amrani, N.; Cacoub, P.; Pèpe, G.ér.; Sabatier, J.-M.; Halfon, P. 2006: Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations Antiviral Therapy 11(7): 847-855